Figure 3.
Blautia-Mediated Attenuation of SI-ALI via Enhanced CD8+ T Cell Founction. (A) Experimental grouping and treatment flowchart for rats. (B) Kaplan-Meier survival analysis: sham-operated group, CLP-induced SI-ALI group, and Blautia-pretreated group. (C) Representative H&E-stained rat lung sections and histological scores of Sham-Operated, CLP, and Blautia-Pretreated Cohorts. (D) Comparison of the Lung Wet/Dry Weight Ratio of rats in each group. (E-H) Peripheral blood T cell frequency and cytokine production: CD3+CD8+ populations, CD3+CD4+ populations, IFN-γ+CD8+ subsets, and Granzyme B+CD8+ subsets in sham-operated group, CLP rats, and Blautia-Pretreated CLP Groups. (I-L) Splenic T cell frequency and effector function: CD3+CD8+ populations, CD3+CD4+ populations, IFN-γ+CD8+ subsets, and Granzyme B+CD8+ subsets in sham-operated group, CLP rats, and Blautia-Pretreated CLP Groups. * P<0.05; ** P<0.01; *** p<0.001; **** p<0.0001.
